PofoliaPofolia ile paylaşıldı

Archives of Osteoporosis· 2013Q2

AB Ülkelerinde Osteoporoz Yükü Detaylandırıldı, Artan Maliyetler ve Azalan Tedavi Ortaya Kondu

Osteoporosis in the European Union: a compendium of country-specific reports

the EU review panel of the IOF, A Svedbom, E Hernlund, M Ivergård ve diğerleri

Kısa özet

2010 yılında AB'de 22 milyon kadın ve 5,5 milyon erkeği etkileyen osteoporoz, 3,5 milyon kırığa ve 37 milyar Avro'luk ekonomik yüke neden oldu; maliyetlerin 2025'e kadar %25 artması bekleniyor.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Ana noktalar

  • 2010 yılında AB'de 22 milyon kadın ve 5,5 milyon erkeğin osteopozu vardı.
  • 2010 yılında AB'de 3,5 milyon kırık meydana geldi ve maliyeti 37 milyar Avro oldu.
  • Osteoporozla ilişkili maliyetlerin 2025'e kadar %25 artması bekleniyor.
  • Osteoporozu olan veya yüksek risk taşıyan bireylerin çoğunluğu tedavi edilmemektedir.
  • Osteoporoz tedavisi alan hasta sayısı azalmaktadır.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Özet (abstract)

UNLABELLED: This report describes epidemiology, burden, and treatment of osteoporosis in each of the 27 countries of the European Union (EU27). INTRODUCTION: In 2010, 22 million women and 5.5 million men were estimated to have osteoporosis in the EU; and 3.5 million new fragility fractures were sustained, comprising 620,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures. The economic burden of incident and prior fragility fractures was estimated at € 37 billion. Previous and incident fractures also accounted for 1,180,000 quality-adjusted life years lost during 2010. The costs are expected to increase by 25 % in 2025. The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining. The aim of this report was to characterize the burden of osteoporosis in each of the EU27 countries in 2010 and beyond. METHODS: The data on fracture incidence and costs of fractures in the EU27 were taken from a concurrent publication in this journal (Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden) and country specific information extracted. RESULTS: The clinical and economic burden of osteoporotic fractures in 2010 is given for each of the 27 countries of the EU. The costs are expected to increase on average by 25 % in 2025. The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining. CONCLUSIONS: In spite of the high cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by aging populations, the use of pharmacological prevention of osteoporosis has decreased in recent years, suggesting that a change in healthcare policy concerning the disease is warranted.

Yazarların özeti; kaynağından alınmıştır. Archives of Osteoporosis, 2013 · DOI ↗

ÇıkarımlarPremium
Makaleye SorÜcretsiz hesapla

Ücretsiz hesapla devam et

Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.

Web'de ücretsiz devam et

Google ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.

Telefonda:

Alan: Ortopedi ve Spor Hekimliği

Orthopedics and Sports MedicineMedicine